Revenue Growth & Gross MarginDurable, double‑digit revenue expansion and a materially higher gross margin indicate the SSi Mantra is gaining commercial traction and achieving scale. Higher gross profit dollars support recurring consumables, service revenue and a pathway to operating leverage as installations and utilization grow.
Strengthened CapitalizationThe $18.6M private placement, led by insider and institutional participation, materially bolsters runway and reduces immediate refinancing risk. A stronger equity base and modest debt improve financial flexibility to fund regulatory submissions, commercial scale-up and working capital needs.
Clinical Adoption & Telesurgery ApprovalsRegulatory approvals and 150+ real-world telesurgeries demonstrate differentiated clinical capability and early product-market fit. Telesurgery competency can expand addressable markets, increase system utilization and drive durable recurring revenue from consumables, services and software.